Symposium subcommittee

Rich is a Regional Programmes Manager at Roche Products Limited. This role is non-promotional focused on NHS regional engagement and collaboration.

Rich previously worked in the NHS, his experiences include 10 years of working in the specialist areas of Haematology, Oncology and Aseptic services at The Clatterbridge Cancer Centre and Wirral University Teaching Hospital.

Susanna Daniels has recently moved to the charity sector as a Project Manager of Melanoma Focus. The charity focuses on commissioning innovative research whilst providing high quality information to patients and healthcare professionals alike. Some of her projects include setting up a melanoma trial database for Health Care Professionals and patients, updating the patient support guide on melanoma and supporting the next biannual conference.

Prior to this, Susanna worked for over 3 years at MSD on pembrolizumab (melanoma and lung cancer) and a trastuzumab biosimilar. Activities involved operationalising the NSCLC EAMS scheme, running advisory boards and training.

All of Susanna’s previous experience is within the NHS in oncology. Her most recent role was as the Lead Cancer Services Pharmacist at UCLH (13 years). She is most proud of creating the renal and hepatic guidelines to support SACT dosing and introducing backpacks to ambulatory care to allow various patient groups have their treatment in the ambulatory setting, thus providing patients with greater autonomy and also freeing up much needed capacity.

Simon is currently a Medical Manager at Pfizer Oncology following 10 years working as an oncology/haematology pharmacist in the NHS. Simon is passionate about patient care and utilising the skills of pharmacists to their fullest. Simon is a current member of the audit & research and education & training sub-committees having previously been a member of the exec committee for 6 years.

Rebecca currently works as an Oncology Pharmacist at the Mount Vernon Cancer Centre in North West London. She has a keen interest in immunotherapy, renal cancer and germ cell tumours.